Cencora said it has completed its $5 billion acquisition of OneOncology, which it bought from private investment firm TPG (TPG.O) in December, deepening its presence in cancer care networks. The company updated its fiscal 2026 forecast to reflect the completion of its acquisition of OneOncology, raising adjusted operating income growth expectations to 11.5% to 13.5% from a previous range of 8% to 10%.
Read the full article: Cencora Completes OneOncology Acquisition //
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/cencora-beats-quarterly-profit-estimates-strong-demand-specialty-medicines-2026-02-04/